| 1 | Study | 1.41% | |
| 2 | Patients | 1.41% | |
| 3 | Tied | 1.41% | |
| 4 | Africa | 1.41% | |
| 5 | Diabetic | 1.41% | |
| 6 | Metabolic | 1.41% | |
| 7 | Patient | 0.7% | |
| 8 | Connecticut | 0.7% | |
| 9 | Prenatal | 0.7% | |
| 10 | Rasmussen | 0.7% | |
| 11 | Antibacterial | 0.7% | |
| 12 | Measles | 0.7% | |
| 13 | Persistent | 0.7% | |
| 14 | Advancing | 0.7% | |
| 15 | Some | 0.7% | |
| 16 | Forms | 0.7% | |
| 17 | Glucagon | 0.7% | |
| 18 | Improved | 0.7% | |
| 19 | Quebec | 0.7% | |
| 20 | CIA | 0.7% | |
| 21 | Risk | 0.7% | |
| 22 | Riyadh | 0.7% | |
| 23 | Vaccine | 0.7% | |
| 24 | Discharge | 0.7% | |
| 25 | June | 0.7% | |
| 26 | Hypertension | 0.7% | |
| 27 | Solutions | 0.7% | |
| 28 | Comprehensive | 0.7% | |
| 29 | Female | 0.7% | |
| 30 | Inhibitor | 0.7% | |
| 31 | DDDT | 0.7% | |
| 32 | Quantification | 0.7% | |
| 33 | PINP | 0.7% | |
| 34 | Implications | 0.7% | |
| 35 | Weigh | 0.7% | |
| 36 | Transplant | 0.7% | |
| 37 | High | 0.7% | |
| 38 | Advancements | 0.7% | |
| 39 | SGLT | 0.7% | |
| 40 | Altered | 0.7% | |
| 41 | Fitness | 0.7% | |
| 42 | Kidney | 0.7% | |
| 43 | New | 0.7% | |
| 44 | Knowledge | 0.7% | |
| 45 | Outcomes | 0.7% | |
| 46 | Expert | 0.7% | |
| 47 | Beyfortus | 0.7% | |
| 48 | Guideline | 0.7% | |
| 49 | Marschall | 0.7% | |
| 50 | Sensorium | 0.7% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||